Europe Hemodialysis and Peritoneal Dialysis Market, By Hemodialysis Products (Hemodialysis Machines, Center-Use Hemodialysis Machines, Home-Use Hemodialysis Machines, Hemodialysis Consumables and Supplies), Dialyzers Material Type (Synthetic Dialyzers, Cellulose-Based Dialyzers), Flux Type (High-Flux, Dialyzers, Low Flux Dialyzers, Bloodlines Sets and Tubes, Hemodialaysis Concentrates/Dialysates, Alkaline Concentrates, Acidic Concentrates, Hemodialysis Access Products, AV Fistula Needles, Arteriovenous Grafts, Central Venous Catheters, Other Hemodialysis Consumables), Hemodialysis Modality (Conventional Hemodialysis, Short Daily Hemodialysis, Nocturnal Hemodialysis (NHD)), Hemodialysis Water Treatment Systems (Central Water Disinfection Systems, Portable Water Disinfection Systems), Peritoneal Dialysis Products and Services (Peritoneal Dialysis Concentrates/Dialysates, Peritoneal Dialysis Machines, Peritoneal Dialysis Catheters, Peritoneal Dialysis Transfer Sets, Other products, Peritoneal Dialysis Services), Peritoneal Dialysis Modality (Continuous Ambulatory Peritoneal Dialysis (CAPD), Ambulatory Peritoneal Dialysis (APD)), Disease Indication (Acute Kidney Infections, End-Stage Renal Disease, Septic Shock, Multi-Organ Failure, Others), Usage (In-Center Dialysis, Hospital Dialysis, Independent Dialysis, Home Dialysis, Peritoneal Dialysis, Home Hemodialysis (HHD)), End User (Hospitals, Dialysis Centers, Home Care Settings) – Industry Trends and Forecast to 2031.
Europe Hemodialysis and Peritoneal Dialysis Market Analysis and Size
The hemodialysis and peritoneal dialysis market has witnessed significant advancements, leveraging the latest methods and technologies. Innovations such as portable dialysis machines and remote monitoring systems have enhanced patient convenience and treatment outcomes. This growth is fueled by increasing prevalence of renal diseases and a growing aging population, driving demand for efficient and accessible renal replacement therapies.
The Europe hemodialysis and peritoneal dialysis market size was valued at USD 26.77 billion in 2023, is projected to reach USD 44.30 billion by 2031, with a CAGR of 6.5% during the forecast period 2024 to 2031. This indicates that the market value. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Hemodialysis Products (Hemodialysis Machines, Center-Use Hemodialysis Machines, Home-Use Hemodialysis Machines, Hemodialysis Consumables and Supplies), Dialyzers Material Type (Synthetic Dialyzers, Cellulose-Based Dialyzers), Flux Type (High-Flux, Dialyzers, Low Flux Dialyzers, Bloodlines Sets and Tubes, Hemodialaysis Concentrates/Dialysates, Alkaline Concentrates, Acidic Concentrates, Hemodialysis Access Products, AV Fistula Needles, Arteriovenous Grafts, Central Venous Catheters, Other Hemodialysis Consumables), Hemodialysis Modality (Conventional Hemodialysis, Short Daily Hemodialysis, Nocturnal Hemodialysis (NHD)), Hemodialysis Water Treatment Systems (Central Water Disinfection Systems, Portable Water Disinfection Systems), Peritoneal Dialysis Products and Services (Peritoneal Dialysis Concentrates/Dialysates, Peritoneal Dialysis Machines, Peritoneal Dialysis Catheters, Peritoneal Dialysis Transfer Sets, Other products, Peritoneal Dialysis Services), Peritoneal Dialysis Modality (Continuous Ambulatory Peritoneal Dialysis (CAPD), Ambulatory Peritoneal Dialysis (APD)), Disease Indication (Acute Kidney Infections, End-Stage Renal Disease, Septic Shock, Multi-Organ Failure, Others), Usage (In-Center Dialysis, Hospital Dialysis, Independent Dialysis, Home Dialysis, Peritoneal Dialysis, Home Hemodialysis (HHD)), End User (Hospitals, Dialysis Centers, Home Care Settings)
|
|
Countries Covered
|
Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe
|
|
Market Players Covered
|
DaVita Inc. (U.S.), Baxter (U.S.), B. Braun SE (Germany), Diaverum AB (Sweden), Nipro Europe Group Companies (Japan), NxStage Medical, Inc. (U.S.), Nikkiso Co., Ltd. (Japan), Evoqua Water Technologies LLC. (U.S.), Asahi Kasei Medical Co., Ltd. (Japan), Rockwell Medical, Inc. (U.S.), Medtronic (Ireland), dialifegroup (Italy), JMS Co.Ltd.(Japan), Atlantic Biomedical (U.S.), 3M (U.S.), Allmed Medical Care Holdings Limited.(China), Isopure Corp.(Taiwan) and BD (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Hemodialysis involves filtering blood outside the body through a machine that acts as an artificial kidney, removing waste and excess fluid. Peritoneal dialysis uses the lining of the abdomen (peritoneum) as a natural filter. Dialysis fluid is introduced into the abdomen, where waste products and excess fluids pass from the blood into the fluid, which is then drained out. Both methods treat kidney failure.
Europe Hemodialysis and Peritoneal Dialysis Market Dynamics
Drivers
- Increasing Prevalence of End-Stage Renal Disease (ESRD)
The escalating prevalence of chronic kidney diseases, such as diabetes and hypertension, fuels the demand for dialysis treatment, propelling market growth. For instance, according to the National Kidney Foundation, approximately 37 million Americans have chronic kidney disease (CKD), with diabetes and high blood pressure being the leading causes. This growing patient pool underscores the imperative for dialysis services, driving innovation and investment in the hemodialysis and peritoneal dialysis market.
- Growing Awareness and Education
Increased awareness campaigns regarding kidney diseases and available treatment options drive early diagnosis and intervention, consequently expanding the patient base for dialysis therapies. For instance, initiatives such as World Kidney Day raise awareness about kidney health globally, encouraging individuals to undergo regular screenings. Early detection enables timely intervention and initiation of dialysis treatment, ultimately fostering market growth by addressing the needs of a larger patient population.
Opportunities
- Rising Preference for Home-Based Dialysis
The preference for home-based dialysis, notably peritoneal dialysis, is surging due to its convenience, cost-effectiveness, and potential to enhance patient outcomes. For instance, in the U.S., the prevalence of home dialysis increased from 15.5% in 2005 to 21.2% in 2016, showcasing a significant shift towards home-based care. This trend reflects a growing recognition among patients and healthcare providers of the benefits associated with home dialysis modalities, propelling market growth in this segment.
- Rising Clinical Advantages of Peritoneal Dialysis
Peritoneal dialysis is gaining traction due to its clinical advantages, including preserving residual kidney function, minimizing dietary restrictions, and offering flexible treatment schedules. For instance, a study published in the Journal of the American Society of Nephrology found that peritoneal dialysis patients retained better residual kidney function compared to those on hemodialysis. Such benefits are driving the increasing adoption of peritoneal dialysis, consequently boosting market demand.
Restraints/Challenges
- High Treatment Costs
The high treatment costs associated with hemodialysis and peritoneal dialysis pose a significant barrier to access, particularly for patients lacking sufficient insurance coverage. This financial burden limits the market's growth potential, as many individuals are unable to afford these therapies, resulting in reduced demand and utilization of dialysis services.
- Limited Availability in Rural Areas
Limited availability of dialysis facilities in rural areas exacerbates healthcare disparities, particularly affecting patients' access to specialized hemodialysis centers. This constraint hampers market growth by restricting treatment options for individuals with end-stage renal disease in remote regions, leading to unequal access to care and potentially poorer health outcomes for those residing in rural areas.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In June 2023, AWAK Technologies and Singapore General Hospital unveiled a pre-pivotal clinical trial assessing the reliability and effectiveness of the upgraded Automated Wearable Artificial Kidney Peritoneal Dialysis (AWAK PD) device, signaling a significant advancement in renal care technology
- In January 2023, the FDA granted regulatory authorization to liberDi Ltd., an Israeli device firm, for its innovative continuous ambulatory peritoneal dialysis system, empowering patients to conveniently perform dialysis at home or work, promising greater autonomy and flexibility in managing their treatment
- In March 2022, Nipro Medical Corporation announced the commercial launch of the SURDIAL DX Hemodialysis System in the United States, introducing state-of-the-art equipment designed to optimize dialysis therapy for both patients and healthcare providers, marking a significant milestone in renal healthcare technology advancement
Europe Hemodialysis and Peritoneal Dialysis Market Scope
The market is segmented on the basis of hemodialysis products, dialyzers material type, flux type, hemodialysis modality, hemodialysis water treatment systems, peritoneal dialysis products and services, peritoneal dialysis modality, disease indication, usage and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Hemodialysis Products
- Hemodialysis Machines
- Center-Use Hemodialysis Machines
- Home-Use Hemodialysis Machines
- Hemodialysis Consumables and Supplies
Dialyzers Material Type
- Synthetic Dialyzers
- Cellulose-Based Dialyzers
Flux Type
- High-Flux
- Dialyzers
- Low Flux Dialyzers
- Bloodlines Sets and Tubes
- Hemodialaysis Concentrates/Dialysates
- Alkaline Concentrates
- Acidic Concentrates
- Hemodialysis Access Products
- AV Fistula Needles
- Arteriovenous Grafts
- Central Venous Catheters
- Other Hemodialysis Consumables
Hemodialysis Modality
- Conventional Hemodialysis
- Short Daily Hemodialysis
- Nocturnal Hemodialysis (NHD)
Hemodialysis Water Treatment Systems
- Central Water Disinfection Systems
- Portable Water Disinfection Systems
Peritoneal Dialysis Products and Services
- Peritoneal Dialysis Concentrates/Dialysates
- Peritoneal Dialysis Machines
- Peritoneal Dialysis Catheters
- Peritoneal Dialysis Transfer Sets
- Other products
Peritoneal Dialysis Modality
- Continuous Ambulatory Peritoneal Dialysis (CAPD)
- Ambulatory Peritoneal Dialysis (APD)
Disease Indication
- Acute Kidney Infections
- End-Stage Renal Disease
- Septic Shock
- Multi-Organ Failure
- Others
Usage
- In-Center Dialysis
- Hospital Dialysis
- Independent Dialysis
- Home Dialysis
- Peritoneal Dialysis
- Home Hemodialysis (HHD)
End User
- Hospitals
- Dialysis Centers
- Home Care Settings
Europe Hemodialysis and Peritoneal Dialysis Market Regional Analysis/Insights
The market is analysed and market size insights and trends are provided by country, hemodialysis products, dialyzers material type, flux type, hemodialysis modality, hemodialysis water treatment systems, peritoneal dialysis products and services, peritoneal dialysis modality, disease indication, usage and end user as referenced above.
The countries covered in the market report are Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, and rest of Europe in Europe.
Germany is expected to dominate the Europe hemodialysis and peritoneal dialysis market due to its robust healthcare facilities, the significant presence of key market players, advanced healthcare infrastructure, and a substantial population afflicted with bone diseases and disorders, ensuring sustained market leadership.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.
Competitive Landscape and Europe Hemodialysis and Peritoneal Dialysis Market Share Analysis
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Some of the major players operating in the market are:
- DaVita Inc. (U.S.)
- Baxter (U.S.)
- B. Braun SE (Germany)
- Diaverum AB (Sweden)
- Nipro Europe Group Companies (Japan)
- NxStage Medical, Inc. (U.S.)
- Nikkiso Co., Ltd. (Japan)
- Evoqua Water Technologies LLC. (U.S.)
- Asahi Kasei Medical Co., Ltd. (Japan)
- Rockwell Medical, Inc. (U.S.)
- Medtronic (Ireland)
- dialifegroup (Italy)
- JMS Co.Ltd.(Japan)
- Atlantic Biomedical (U.S.)
- 3M (U.S.)
- Allmed Medical Care Holdings Limited. (China)
- Isopure Corp. (Taiwan)
- BD (U.S.)
SKU-